title: Use of intravitreous bevacizumab to treat macular edema in West Nile virus chorioretinitis.
authors.forename: Armin R
authors.initials: AR
authors.lastname: Afshar
authors.forename: Seenu M
authors.initials: SM
authors.lastname: Hariprasad
authors.forename: Lee M
authors.initials: LM
authors.lastname: Jampol
authors.forename: Veeral S
authors.initials: VS
authors.lastname: Sheth
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000068258:Bevacizumab; D002825:Chorioretinitis / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D008297:Male; D014901:West Nile Fever / Q000150:complications*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab